Skip to main content

Advertisement

SpringerLink
Log in

Association between clusterin concentration and dementia: a systematic review and meta-analysis

  • Original Article
  • Published:
Metabolic Brain Disease Aims and scope Submit manuscript

Abstract

Studies have showed that high clusterin (CLU) concentration was associated with increased risk of dementia. However, the results based on small samples remained controversial. The aim of our study was to determine the relationship between CLU concentration and the late-life cognitive outcomes including mild cognitive impairment (MCI), Alzheimer’s disease (AD), vascular dementia (VAD), Parkinson’s disease related dementia (PDD), Lewy body dementia (DLB) and frontotemporal dementia (FTD). A comprehensive search was conducted to screen the eligible studies in online database PubMed, Web of Science and Embase from 1950 to January 2017 according to the preferred reporting items for systematic reviews and meta-analyses (PRISMA) checklist. The CLU concentration data in brain tissue, cerebrospinal fluid (CSF), serum and plasma was collected to determine the strength of this association. The results were presented with standard difference of the mean (SDM) with 95% confidence intervals (CIs). A total of 28 studies were identified to calculate the association between CLU concentration and dementia. The results showed that the CLU concentration in the plasma (SDM = 0.73, 95% CI 0.26–1.19, P = 0.002) and brain tissue (SDM = 0.71, 95% CI 0.10–1.32, P = 0.022) was increased in dementia compared to normal control. Subgroup analysis showed that the plasma CLU concentration was significantly increased only in the AD group (SDM = 1.85, 95% CI 0.84–2.85, P < 0.001), but not in MCI or other dementias. No association was found between serum and CSF clusterin concentration and dementia. This meta-analysis indicates that high CLU concentration in the plasma and brain is associated with dementia, especially in AD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  • Bertrand P, Poirier J, Oda T, Finch CE, Pasinetti GM (1995) Association of apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (clusterin) in Alzheimer disease. Brain Res Mol Brain Res 33:174–178

    Article  CAS  Google Scholar 

  • Bettens K, Vermeulen S, Van Cauwenberghe C, Heeman B, Asselbergh B, Robberecht C, Engelborghs S, Vandenbulcke M, Vandenberghe R, De Deyn PP, Cruts M, Van Broeckhoven C, Sleegers K (2015) Reduced secreted clusterin as a mechanism for Alzheimer-associated CLU mutations. Mol Neurodegener 10:30

    Article  Google Scholar 

  • Cai R, Han J, Sun J, Huang R, Tian S, Shen Y, Dong X, Xia W, Wang S (2016) Plasma Clusterin and the CLU gene rs11136000 variant are associated with mild cognitive impairment in type 2 diabetic patients. Front Aging Neurosci 8:179

    Article  Google Scholar 

  • Chen J, Wang M, Turko IV (2012) Mass spectrometry quantification of clusterin in the human brain. Mol Neurodegener 7:41

    Article  CAS  Google Scholar 

  • DeMattos RB, Cirrito JR, Parsadanian M, May PC, O'Dell MA, Taylor JW, Harmony JA, Aronow BJ, Bales KR, Paul SM, Holtzman DM (2004) ApoE and clusterin cooperatively suppress Abeta levels and deposition: evidence that ApoE regulates extracellular Abeta metabolism in vivo. Neuron 41:193–202

    Article  CAS  Google Scholar 

  • Deming Y, Xia J, Cai Y, Lord J, Holmans P, Bertelsen S, Holtzman D, Morris JC, Bales K, Pickering EH, Kauwe J, Goate A, Cruchaga C (2016) A potential endophenotype for Alzheimer's disease: cerebrospinal fluid clusterin. Neurobiol Aging 37:208.e1–208.e9

    Article  CAS  Google Scholar 

  • Desikan RS, Thompson WK, Holland D, Hess CP, Brewer JB, Zetterberg H, Blennow K, Andreassen OA, McEvoy LK, Hyman BT, Dale AM (2014) The role of clusterin in amyloid-beta-associated neurodegeneration. JAMA NEUROL 71:180–187

    Article  Google Scholar 

  • Du W, Tan J, Xu W, Chen J, Wang L (2016) Association between clusterin gene polymorphism rs11136000 and late-onset Alzheimer's disease susceptibility: a review and meta-analysis of case-control studies. EXP THER MED 12:2915–2927

    Article  CAS  Google Scholar 

  • Dukic L, Simundic AM, Martinic-Popovic I, Kackov S, Diamandis A, Begcevic I, Diamandis EP (2016) The role of human kallikrein 6, clusterin and adiponectin as potential blood biomarkers of dementia. Clin Biochem 49:213–218

    Article  CAS  Google Scholar 

  • Ferrari R, Moreno JH, Minhajuddin AT, O'Bryant SE, Reisch JS, Barber RC, Momeni P (2012) Implication of common and disease specific variants in CLU, CR1, and PICALM. Neurobiol Aging 33:1846–1847

    PubMed  Google Scholar 

  • Golabek A, Marques MA, Lalowski M, Wisniewski T (1995) Amyloid beta binding proteins in vitro and in normal human cerebrospinal fluid. Neurosci Lett 191:79–82

    Article  CAS  Google Scholar 

  • Golebiewska EM, Poole AW (2015) Platelet secretion: from haemostasis to wound healing and beyond. Blood Rev 29:153–162

    Article  CAS  Google Scholar 

  • Gupta VB, Doecke JD, Hone E, Pedrini S, Laws SM, Thambisetty M, Bush AI, Rowe CC, Villemagne VL, Ames D, Masters CL, Macaulay SL, Rembach A, Rainey-Smith SR, Martins RN (2016) Plasma apolipoprotein J as a potential biomarker for Alzheimer's disease: Australian imaging. Biomarkers and Lifestyle Study of Aging Alzheimers Dement (Amst) 3:18–26

    Google Scholar 

  • Hakobyan S, Harding K, Aiyaz M, Hye A, Dobson R, Baird A, Liu B, Harris CL, Lovestone S, Morgan BP (2016) Complement biomarkers as predictors of disease progression in Alzheimer's disease. J Alzheimers Dis 54:707–716

    Article  CAS  Google Scholar 

  • Harr SD, Uint L, Hollister R, Hyman BT, Mendez AJ (1996) Brain expression of apolipoproteins E, J, and A-I in Alzheimer's disease. J Neurochem 66:2429–2435

    Article  CAS  Google Scholar 

  • Hughes TM, Lopez OL, Evans RW, Kamboh MI, Williamson JD, Klunk WE, Mathis CA, Price JC, Cohen AD, Snitz BE, Dekosky ST, Kuller LH (2014) Markers of cholesterol transport are associated with amyloid deposition in the brain. Neurobiol Aging 35:802–807

    Article  CAS  Google Scholar 

  • Ijsselstijn L, Dekker LJM, Koudstaal PJ, Hofman A, Sillevis Smitt PAE, Breteler MMB, Luider TM (2011) Serum clusterin levels are not increased in presymptomatic Alzheimers disease. J Proteome Res 10:2006–2010

    Article  CAS  Google Scholar 

  • Jongbloed W, Herrebout MA, Blankenstein MA, Veerhuis R (2014) Quantification of clusterin in paired cerebrospinal fluid and plasma samples. Ann Clin Biochem 51:557–567

    Article  CAS  Google Scholar 

  • Jongbloed W, van Dijk KD, Mulder SD, van de Berg WD, Blankenstein MA, van der Flier W, Veerhuis R (2015) Clusterin levels in plasma predict cognitive decline and progression to Alzheimer's disease. J Alzheimers Dis 46:1103–1110

    Article  CAS  Google Scholar 

  • Kim N, Choi WS (2011) Proapoptotic role of nuclear clusterin in brain. Anatomy & Cell Biology 44:169–175

    Article  Google Scholar 

  • Kim N, Yoo JC, Han JY, Hwang EM, Kim YS, Jeong EY, Sun CH, Yi GS, Roh GS, Kim HJ (2012) Human nuclear clusterin mediates apoptosis by interacting with Bcl-XL through C-terminal coiled coil domain. J Cell Physiol 227:1157–1167

    Article  CAS  Google Scholar 

  • Lidstrom AM, Bogdanovic N, Hesse C, Volkman I, Davidsson P, Blennow K (1998) Clusterin (apolipoprotein J) protein levels are increased in hippocampus and in frontal cortex in Alzheimer's disease. Exp Neurol 154:511–521

    Article  CAS  Google Scholar 

  • Lidstrom AM, Hesse C, Rosengren L, Fredman P, Davidsson P, Blennow K (2001) Normal levels of clusterin in cerebrospinal fluid in Alzheimer's disease, and no change after acute ischemic stroke. J Alzheimers Dis 3:435–442

    Article  CAS  Google Scholar 

  • Liu CC, Zhao N, Yamaguchi Y, Cirrito JR, Kanekiyo T, Holtzman DM, Bu G (2016) Neuronal heparan sulfates promote amyloid pathology by modulating brain amyloid-beta clearance and aggregation in Alzheimer's disease. Sci Transl Med 8:332r–344r

    Google Scholar 

  • Lu SJ, Li HL, Sun YM, Liu ZJ, Yang P, Wu ZY (2014) Clusterin variants are not associated with southern Chinese patients with Alzheimer's disease. Neurobiol Aging 35:2656–2659

    Article  Google Scholar 

  • Macaulay IC, Carr P, Gusnanto A, Ouwehand WH, Fitzgerald D, Watkins NA (2005) Platelet genomics and proteomics in human health and disease. J Clin Invest 115:3370–3377

    Article  CAS  Google Scholar 

  • Meng Y, Li H, Hua R, Wang H, Lu J, Yu X, Zhang C (2015) A correlativity study of plasma APL1beta28 and clusterin levels with MMSE/MoCA/CASI in aMCI patients. Sci Rep 5:15546

    Article  CAS  Google Scholar 

  • Mukaetova-Ladinska EB, Abdel-All Z, Dodds S, Andrade J, Alves Da Silva J, Kalaria RN, O'Brien JT (2012) Platelet immunoglobulin and amyloid precursor protein as potential peripheral biomarkers for Alzheimer's disease: findings from a pilot study. Age Ageing 41:408–412

    Article  Google Scholar 

  • Mukaetova-Ladinska EB, Abdel-All Z, Andrade J, Alves DSJ, O'Brien JT, Kalaria RN (2015) Plasma and platelet clusterin ratio is altered in Alzheimer's disease patients with distinct neuropsychiatric symptoms: findings from a pilot study. Int J Geriatr Psychiatry 30:368–375

    Article  Google Scholar 

  • Mullan GM, McEneny J, Fuchs M, McMaster C, Todd S, McGuinness B, Henry M, Passmore AP, Young IS, Johnston JA (2013) Plasma clusterin levels and the rs11136000 genotype in individuals with mild cognitive impairment and Alzheimer's disease. Curr Alzheimer Res 10:973–978

    Article  CAS  Google Scholar 

  • Nilselid AM, Davidsson P, Nagga K, Andreasen N, Fredman P, Blennow K (2006) Clusterin in cerebrospinal fluid: analysis of carbohydrates and quantification of native and glycosylated forms. Neurochem Int 48:718–728

    Article  CAS  Google Scholar 

  • Nuutinen T, Suuronen T, Kauppinen A, Salminen A (2009) Clusterin: a forgotten player in Alzheimer's disease. Brain Res Rev 61:89–104

    Article  CAS  Google Scholar 

  • Ossenkoppele R, van der Flier WM, Zwan MD, Adriaanse SF, Boellaard R, Windhorst AD, Barkhof F, Lammertsma AA, Scheltens P, van Berckel BN (2013) Differential effect of APOE genotype on amyloid load and glucose metabolism in AD dementia. Neurology 80:359–365

    Article  CAS  Google Scholar 

  • Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP (2013) The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement 9:63–75

    Article  Google Scholar 

  • Puchades M, Hansson SF, Nilsson CL, Andreasen N, Blennow K, Davidsson P (2003) Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease. Brain Res Mol Brain Res 118:140–146

    Article  CAS  Google Scholar 

  • Richens JL, Vere KA, Light RA, Soria D, Garibaldi J, Smith AD, Warden D, Wilcock G, Bajaj N, Morgan K, O'Shea P (2014) Practical detection of a definitive biomarker panel for Alzheimer's disease; comparisons between matched plasma and cerebrospinal fluid. International Journal of Molecular Epidemiology and Genetics 5:53–70

    CAS  PubMed  PubMed Central  Google Scholar 

  • Savkovic V, Gantzer H, Reiser U, Selig L, Gaiser S, Sack U, Kloppel G, Mossner J, Keim V, Horn F, Bodeker H (2007) Clusterin is protective in pancreatitis through anti-apoptotic and anti-inflammatory properties. Biochem Biophys Res Commun 356:431–437

    Article  CAS  Google Scholar 

  • Schrijvers EM, Koudstaal PJ, Hofman A, Breteler MM (2011) Plasma clusterin and the risk of Alzheimer disease. JAMA 305:1322–1326

    Article  CAS  Google Scholar 

  • Schurmann B, Wiese B, Bickel H, Weyerer S, Riedel-Heller SG, Pentzek M, Bachmann C, Williams J, van den Bussche H, Maier W, Jessen F (2011) Association of the Alzheimer's disease clusterin risk allele with plasma clusterin concentration. J Alzheimers Dis 25:421–424

    Article  Google Scholar 

  • Shuai P, Liu Y, Lu W, Liu Q, Li T, Gong B (2015) Genetic associations of CLU rs9331888 polymorphism with Alzheimer's disease: a meta-analysis. Neurosci Lett 591:160–165

    Article  CAS  Google Scholar 

  • Silajdzic E, Minthon L, Bjorkqvist M, Hansson O (2012) No diagnostic value of plasma clusterin in Alzheimer's disease. PLoS One 7:e50237

    Article  CAS  Google Scholar 

  • Solomon A, Soininen H (2015) Dementia: risk prediction models in dementia prevention. NAT REV NEUROL 11:375–377

    Article  Google Scholar 

  • Song F, Poljak A, Crawford J, Kochan NA, Wen W, Cameron B, Lux O, Brodaty H, Mather K, Smythe GA, Sachdev PS (2012). Plasma Apolipoprotein Levels Are Associated with Cognitive Status and Decline in a Community Cohort of Older Individuals PLOS ONE 7

  • Tan L, Wang HF, Tan MS, Tan CC, Zhu XC, Miao D, Yu WJ, Jiang T, Tan L, Yu JT (2016) Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer's disease cohorts. Sci Rep 6:26027

    Article  CAS  Google Scholar 

  • Thambisetty M, Simmons A, Velayudhan L, Hye A, Campbell J, Zhang Y, Wahlund LO, Westman E, Kinsey A, Guntert A, Proitsi P, Powell J, Causevic M, Killick R, Lunnon K, Lynham S, Broadstock M, Choudhry F, Howlett DR, Williams RJ, Sharp SI, Mitchelmore C, Tunnard C, Leung R, Foy C, O'Brien D, Breen G, Furney SJ, Ward M, Kloszewska I, Mecocci P, Soininen H, Tsolaki M, Vellas B, Hodges A, Murphy DG, Parkins S, Richardson JC, Resnick SM, Ferrucci L, Wong DF, Zhou Y, Muehlboeck S, Evans A, Francis PT, Spenger C, Lovestone S (2010) Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease. Arch Gen Psychiatry 67:739–748

    Article  Google Scholar 

  • Thambisetty M, An Y, Kinsey A, Koka D, Saleem M, Guntert A, Kraut M, Ferrucci L, Davatzikos C, Lovestone S, Resnick SM (2012) Plasma clusterin concentration is associated with longitudinal brain atrophy in mild cognitive impairment. NeuroImage 59:212–217

    Article  CAS  Google Scholar 

  • Trougakos IP (2013) The molecular chaperone apolipoprotein J/clusterin as a sensor of oxidative stress: implications in therapeutic approaches - a mini-review. Gerontology 59:514–523

    Article  CAS  Google Scholar 

  • Villemagne VL, Burnham S, Bourgeat P, Brown B, Ellis KA, Salvado O, Szoeke C, Macaulay SL, Martins R, Maruff P, Ames D, Rowe CC, Masters CL (2013) Amyloid beta deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study. Lancet Neurol 12:357–367

    Article  CAS  Google Scholar 

  • Vishnu VY, Modi M, Sharma S, Mohanty M, Goyal MK, Lal V, Khandelwal N, Mittal BR, Prabhakar S (2016) Role of plasma Clusterin in Alzheimer's disease-a pilot study in a tertiary Hospital in Northern India. PLoS One 11:e166369

    Article  Google Scholar 

  • Weinstein G, Beiser AS, Preis SR, Courchesne P, Chouraki V, Levy D, Seshadri S (2016) Plasma clusterin levels and risk of dementia, Alzheimer's disease, and stroke. Alzheimers Dement (Amst) 3:103–109

    Google Scholar 

  • Xing YY, Yu JT, Cui WZ, Zhong XL, Wu ZC, Zhang Q, Tan L (2012) Blood clusterin levels, rs9331888 polymorphism, and the risk of Alzheimer's disease. J Alzheimers Dis 29:515–519

    Article  CAS  Google Scholar 

  • Yerbury JJ, Poon S, Meehan S, Thompson B, Kumita JR, Dobson CM, Wilson MR (2007) The extracellular chaperone clusterin influences amyloid formation and toxicity by interacting with prefibrillar structures. FASEB J 21:2312–2322

    Article  CAS  Google Scholar 

  • Yu J, Tan L (2012) The role of clusterin in Alzheimer’s disease: pathways, pathogenesis, and therapy. Mol Neurobiol 45:314–326

    Article  CAS  Google Scholar 

  • Zhang S, Zhang D, Jiang Y, Wu L, Shang H, Liu J, Feng R, Liao M, Zhang L, Liu Y, Liu G, Li K (2015) CLU rs2279590 polymorphism contributes to Alzheimer's disease susceptibility in Caucasian and Asian populations. J Neural Transm (Vienna) 122:433–439

    Article  CAS  Google Scholar 

  • Zhou Y, Hayashi I, Wong J, Tugusheva K, Renger JJ, Zerbinatti C (2014) Intracellular clusterin interacts with brain isoforms of the bridging integrator 1 and with the microtubule-associated protein tau in Alzheimer's disease. PLoS One 9:e103187

    Article  Google Scholar 

Download references

Author information

Author notes

  1. Caiping Yang and Hai Wang contributed equally to this work and should be regarded as co-first authors.

Authors and Affiliations

  1. Department of Neurology, Hospital of Zhuozhou, Zhuozhou, 072750, Hebei, China

    Caiping Yang, Hai Wang & Huiyan Niu

  2. The Middle School Attached to Northwestern Polytechnical University, Xi’an, 710068, China

    Chaojiu Li

  3. Department of Endocrinology and Metabolism, the Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, 519000, China

    Shunkui Luo & Xingzhi Guo

Authors
  1. Caiping Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hai Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chaojiu Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Huiyan Niu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shunkui Luo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Xingzhi Guo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xingzhi Guo.

Ethics declarations

Conflicts of interest

The authors declare no conflicts of interest.

Electronic supplementary material

ESM 1

(DOC 30 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yang, C., Wang, H., Li, C. et al. Association between clusterin concentration and dementia: a systematic review and meta-analysis. Metab Brain Dis 34, 129–140 (2019). https://doi.org/10.1007/s11011-018-0325-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11011-018-0325-0

Keywords

Search

Navigation